연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
1781. Preoperative staging of non-small cell lung cancer: prospective comparison of PET/MR and PET/CT.
Sang Min Lee, Jin Mo Goo Email author , Chang Min Park, Soon Ho Yoon, Jin Chul Paeng, Gi Jeong Cheon, Young Tae Kim, Young Sik Park
Eur Radiol. 2016 Nov;26(11):3850-3857. Epub 2016 Feb 16.
Link
1780. Improving gastric cancer preclinical studies using diverse in vitro and in vivo model systems.
Chang HR, Park HS, Ahn YZ, Nam S, Jung HR, Park S, Lee SJ, Balch C, Powis G, Ku JL, Kim YH.
BMC Cancer. 2016 Mar 9;16:200. doi: 10.1186/s12885-016-2232-2.
Link
1779. Antitumor effects of calgranulin B internalized in human colon cancer cells.
Kim K, Kim KH, Roh K, Yoo BC, Ku JL, Shin YK, Cho JY, Kim M, Kwon MH, Goh SH, Chang HJ, Oh JH
Oncotarget. 2016 Apr 12;7(15):20368-80. doi: 10.18632/oncotarget.7783.
Link
1778. Improved Outcome of a Reduced Toxicity-Fludarabine, Cyclophosphamide, plus Antithymocyte Globulin Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia: Comparison of 2 Multicenter Prospective Studies.
Kang HJ, Hong KT, Lee JW, Kim H, Park KD, Shin HY, Lee SH, Yoo KH, Sung KW, …..Lee JH, Park JA, Park SK, Ahn HS; Korean Society of Pediatric Hematology-Oncology.
Biol Blood Marrow Transplant. 2016 Aug;22(8):1455-9. doi: 10.1016/j.bbmt.2016.04.003. Epub 2016 May 8.
Link
1777. Half-dose ganciclovir preemptive treatment of cytomegalovirus infection after pediatric allogeneic hematopoietic stem cell transplantation.
Ju HY, Kang HJ, Hong CR, Lee JW, Kim H, Park KD, Shin HY, Park JD, Choi EH, Lee HJ, Ahn HS.
Transpl Infect Dis. 2016 Jun;18(3):396-404. doi: 10.1111/tid.12539. Epub 2016 Jun 9.
Link
1776. Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers.
Kim JH, Park HE, Cho NY, Lee HS, Kang GH.
Br J Cancer. 2016 Aug 9;115(4):490-6. doi: 10.1038/bjc.2016.211. Epub 2016 Jul 12.
Link
1775. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH, Bae JM, Cho NY, Kang GH.
Oncotarget. 2016 Mar 22;7(12):14095-111. doi: 10.18632/oncotarget.7374.
Link
1774. Clinicopathologic, molecular, and prognostic implications of the loss of EPCAM expression in colorectal carcinoma.
Kim JH, Bae JM, Song YS, Cho NY, Lee HS, Kang GH.
Oncotarget. 2016 Mar 22;7(12):13372-87. doi: 10.18632/oncotarget.5618.
Link
1773. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
Bae JM1, Rhee YY2, Kim KJ3, Wen X4, Song YS5, Cho NY6, Kim JH7, Kang GH8.
Hum Pathol. 2016 Jan;47(1):85-94. doi: 10.1016/j.humpath.2015.09.008. Epub 2015 Sep 25.
Link
1772. Distribution of intestinal stem cell markers in colorectal precancerous lesions.
Jang BG, Kim HS, Kim KJ, Rhee YY, Kim WH, Kang GH.
Histopathology. 2016 Mar;68(4):567-77. doi: 10.1111/his.12787. Epub 2015 Sep 11.
Link